 antifung treatment amphotericin delay recoveri normal hematopoiet cell intens cytostat therapi acut myeloid leukemia system fungal infect frequenc cours intens therapi acut leukemia parenter antifung treatment amphotericin combin potenti myelosuppress side effect aim current studi recoveri hematopoiet cell intens antileukem therapi patient ampho treatment proven system fungal infect studi popul patient standard chemotherapi acut myeloid leukemia aml first diagnosi relaps twenty-two patient underw system antifung therapi consist ampho mg/kg/d mg/kg/d day median day patient control hematolog recoveri time TR interv onset chemotherapi post-treat rise granulocyt level cmm thrombocyt level cmm patient antifung therapi signific prolong TR median TR day median TR day control group correl TR total dose ampho type antileukem regimen direct myelosuppress effect fungal infect unlik find ampho treatment patient proven suspect fungal infect similar delay TR group present data myelosuppress effect ampho antifung treatment patient intens chemotherapi acut leukemia